86
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase

, &
Pages 293-314 | Published online: 08 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jiachang Gong, Timothy Eley, Bing He, Vinod Arora, Thomas Philip, Hao Jiang, John Easter, W. Griffith Humphreys, Ramaswamy A. Iyer & Wenying Li. (2016) Characterization of ADME properties of [14C]asunaprevir (BMS-650032) in humans. Xenobiotica 46:1, pages 52-64.
Read now

Articles from other publishers (16)

Amrita Saha, Badri Narayan Acharya, Raj Priya, Nagesh K. Tripathi, Ambuj Shrivastava, M. Kameswara Rao, Pooja Kesari, Manju Narwal, Shailly Tomar, Sameer S. Bhagyawant, Manmohan Parida & Paban Kumar Dash. (2018) Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus. Scientific Reports 8:1.
Crossref
Kattareeya Kumthip & Niwat Maneekarn. (2015) The role of HCV proteins on treatment outcomes. Virology Journal 12:1.
Crossref
Soumendranath Bhakat, Wilson Karubiu, Venkatesan Jayaprakash & Mahmoud E.S. Soliman. (2014) A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses. European Journal of Medicinal Chemistry 87, pages 677-702.
Crossref
Thien Duc Tran, Florian Wakenhut, Chris Pickford, Stephen Shaw, Mike Westby, Caroline Smith-Burchnell, Lesa Watson, Michael Paradowski, Jared Milbank, Rebecca A. Brimage, Rebecca Halstead, Rebecca Glen, Craig P. Wilson, Fiona Adam, Duncan Hay, Jean-Yves Chiva, Carly Nichols, David C. Blakemore, Iain Gardner, Satish Dayal, Andrew Pike, Rob Webster & David C. Pryde. (2014) The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile-Part 1. ChemMedChem 9:7, pages 1378-1386.
Crossref
Makonen Belema, Omar D. Lopez, John A. Bender, Jeffrey L. Romine, Denis R. St. Laurent, David R. Langley, Julie A. Lemm, Donald R. O’BoyleIIII, Jin-Hua Sun, Chunfu Wang, Robert A. Fridell & Nicholas A. Meanwell. (2014) Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors. Journal of Medicinal Chemistry 57:5, pages 1643-1672.
Crossref
Maria Victoria Preciado, Pamela Valva, Alejandro Escobar-Gutierrez, Paula Rahal, Karina Ruiz-Tovar, Lilian Yamasaki, Carlos Vazquez-Chacon, Armando Martinez-Guarneros, Juan Carlos Carpio-Pedroza, Salvador Fonseca-Coronado & Mayra Cruz-Rivera. (2014) Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapy. World Journal of Gastroenterology 20:43, pages 15992.
Crossref
Donald R. O'Boyle II, Jin-Hua Sun, Peter T. Nower, Julie A. Lemm, Robert A. Fridell, Chunfu Wang, Jeffrey L. Romine, Makonen Belema, Van N. Nguyen, Denis R. St. Laurent, Michael Serrano-Wu, Lawrence B. Snyder, Nicholas A. Meanwell, David R. Langley & Min Gao. (2013) Characterizations of HCV NS5A replication complex inhibitors. Virology 444:1-2, pages 343-354.
Crossref
David C. Pryde, Thien-Duc Tran, Mark Gardner, Chris Pickford, Stephen M. Shaw, Mike Westby, Tanya Parkinson, Caroline Smith-Burchnell, Rob Webster & Satish Dayal. (2013) Identification of HCV Inhibitors from a Cell-Based Sub-Genomic Replicon Screen. Open Journal of Medicinal Chemistry 03:01, pages 16-25.
Crossref
Tarik Asselah & Patrick Marcellin. (2012) Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow. Liver International 32, pages 88-102.
Crossref
Tarik Asselah. (2011) NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis C. Journal of Hepatology 54:5, pages 1069-1072.
Crossref
Frank Narjes, Benedetta Crescenzi, Marco Ferrara, Jörg Habermann, Stefania Colarusso, Maria del Rosario Rico Ferreira, Ian Stansfield, Angela Claire Mackay, Immacolata Conte, Caterina Ercolani, Simone Zaramella, Maria-Cecilia Palumbi, Philip Meuleman, Geert Leroux-Roels, Claudio Giuliano, Fabrizio Fiore, Stefania Di Marco, Paola Baiocco, Uwe Koch, Giovanni Migliaccio, Sergio Altamura, Ralph Laufer, Raffaele De Francesco & Michael Rowley. (2010) Discovery of (7 R )-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6 H -indolo[1,2- e ][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase . Journal of Medicinal Chemistry 54:1, pages 289-301.
Crossref
Nicholas A. Meanwell & Makonen Belema. 2011. 263 282 .
Tanya ParkinsonDavid C Pryde. (2010) Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus. Future Medicinal Chemistry 2:7, pages 1181-1203.
Crossref
Min Gao, Richard E. Nettles, Makonen Belema, Lawrence B. Snyder, Van N. Nguyen, Robert A. Fridell, Michael H. Serrano-Wu, David R. Langley, Jin-Hua Sun, Donald R. O’Boyle II, Julie A. Lemm, Chunfu Wang, Jay O. Knipe, Caly Chien, Richard J. Colonno, Dennis M. Grasela, Nicholas A. Meanwell & Lawrence G. Hamann. (2010) Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465:7294, pages 96-100.
Crossref
Julie A. Lemm, Donald O'BoyleIIII, Mengping Liu, Peter T. Nower, Richard Colonno, Milind S. Deshpande, Lawrence B. Snyder, Scott W. Martin, Denis R. St. Laurent, Michael H. Serrano-Wu, Jeffrey L. Romine, Nicholas A. Meanwell & Min Gao. (2010) Identification of Hepatitis C Virus NS5A Inhibitors. Journal of Virology 84:1, pages 482-491.
Crossref
Nicholas A. Meanwell, John F. Kadow & Paul M. Scola. 2009. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry Volume 44 397 440 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.